Chanling Gao suppresses colorectal cancer via PI3K /Akt/ mTOR pathway modulation and enhances quality of survival
Environmental Toxicology · 2024
DOI: 10.1002/tox.23994 ↗Kurz gefasst
Fachartikel in der Zeitschrift Environmental Toxicology, 2024. Verfasst von Guo Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, The First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine, Guiyang, China. Hauptthemen laut MEDLINE: Liver Neoplasms, Colorectal Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: 2021 Research Innovation and Exploration Special Project of Guizhou University of Traditional Chinese Medicine, High-Level Innovative Talents Training Program of Guizhou Province, Massive Health Science and Technology Cooperation Project of the First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine.
Abstract (Originalsprache)
The Chinese medicine formula Chanling Gao (CLG) exhibits significant tumor inhibitory effects in colorectal cancer (CRC) nude mice. However, the detailed mechanisms remain elusive. CRC in situ nude mouse models were treated with CLG. Small animal magnetic resonance imaging (MRI) tracked tumor progression, and overall health metrics such as food and water intake, body weight, and survival were monitored. Posttreatment, tissues and blood were analyzed for indicators of tumor inhibition and systemic effects. Changes in vital organs were observed via stereoscope and hematoxylin‐eosin staining. Immunohistochemistry quantified HIF‐1α and P70S6K1 protein expression in xenografts. Double labeling was used to statistically analyze vascular endothelial growth factor (VEGF) and CD31 neovascularization. Enzyme‐linked immunosorbent assay was used to determine the levels of VEGF, MMP‐2, MMP‐9, IL‐6, and IL‐10 in serum, tumors, and liver. Western blotting was used to assess the expression of the PI3K/Akt/mTOR signaling pathway‐related factors TGF‐β1 and smad4 in liver tissues. CLG inhibited tumor growth, improved overall health metrics, and ameliorated abnormal blood cell counts in CRC nude mice. CLG significantly reduced tumor neovascularization and VEGF expression in tumors and blood. It also suppressed HIF‐1α, EGFR, p‐PI3K, Akt, p‐Akt, and p‐mTOR expression in tumors while enhancing PTEN oncogene expression. Systemic improvements were noted, with CLG limiting liver metastasis, reducing pro‐inflammatory cytokines IL‐6 and IL‐10 in liver tissues, decreasing MMP‐2 in blood and MMP‐2 and MMP‐9 in tumors, and inhibiting TGF‐β1 expression in liver tissues. CLG can enhance survival quality and inhibit tumor growth in CRC nude mice, likely through the regulation of the PI3K/Akt/mTOR signaling pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, The First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine, Guiyang, China.
- Key Laboratory of Microcirculation, State Administration of Traditional Chinese Medicine of the People's Republic of China, Beijing, China.
- Department of Integration of Chinese and Western Medicine, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China.
ORCID-Profile: Jing-Yan Han
Förderung
- 2021 Research Innovation and Exploration Special Project of Guizhou University of Traditional Chinese Medicine
- High-Level Innovative Talents Training Program of Guizhou Province
- Massive Health Science and Technology Cooperation Project of the First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine
- National Natural Science Foundation of China
- Postgraduate workstation of TCM oncology
- Science and Technology Planning Project of Guizhou province
- TCM Tumor Inheritance and Science and Technology Innovation Talent Base of Guizhou Province
- Yang Zhu "TCM Oncology" Postgraduate Mentorship Workshop of Guizhou Province
Zitieren
APA
Chen, G., Tian, T. T., Wang, F. Q., Pan, C. S., Sun, K., Wang, X. Y., Yang, B., Yang, Z., Tang, D. X., & Han, J. Y. (2024). Chanling Gao suppresses colorectal cancer via PI3K /Akt/ mTOR pathway modulation and enhances quality of survival. Environmental Toxicology. https://doi.org/10.1002/tox.23994
Vancouver
Chen G, Tian TT, Wang FQ, Pan CS, Sun K, Wang XY, et al. Chanling Gao suppresses colorectal cancer via PI3K /Akt/ mTOR pathway modulation and enhances quality of survival. Environmental Toxicology. 2024. doi:10.1002/tox.23994
BibTeX
@article{Chen2024,
author = {Chen, Guo and Tian, Ting-Ting and Wang, Fei-Qing and Pan, Chun-Shui and Sun, Kai and Wang, Xiao-Yi and Yang, Bing and Yang, Zhu and Tang, Dong-Xin and Han, Jing-Yan},
title = {Chanling Gao suppresses colorectal cancer via PI3K /Akt/ mTOR pathway modulation and enhances quality of survival},
journal = {Environmental Toxicology},
year = {2024},
doi = {10.1002/tox.23994}
}
EUVIMED